Triple negative breast cancer and skin metastasis
Pro Research Analysisby 
Searched over 200M research papers
Triple-Negative Breast Cancer (TNBC) Metastasis: Aggressiveness and Patterns
Triple-negative breast cancer (TNBC) is known for its aggressive nature, early metastasis, and poor prognosis, especially compared to other breast cancer subtypes. TNBC often affects younger women and is characterized by the absence of estrogen, progesterone, and HER2 receptors, making it unresponsive to many standard targeted therapies. Metastatic TNBC is particularly challenging to treat and is associated with a high risk of recurrence and rapid progression to secondary sites, including the skin, lungs, brain, and bone Bergin2019Neophytou2018Al-Mahmood2018.
Skin Metastasis in TNBC: Clinical Relevance
While TNBC can metastasize to various organs, skin metastasis is a recognized but less common manifestation. The aggressive biology of TNBC, including its tendency for early and widespread dissemination, increases the risk of cutaneous involvement. Skin metastases may present as nodules, plaques, or inflammatory lesions and often indicate advanced disease with a poor prognosis Bergin2019Neophytou2018.
Molecular Mechanisms Driving TNBC Metastasis
Epithelial-Mesenchymal Transition (EMT) and Metastatic Spread
A key driver of TNBC metastasis, including to the skin, is the process of epithelial-mesenchymal transition (EMT). EMT enables cancer cells to become more mobile and invasive, facilitating their spread from the primary tumor to distant sites. TNBC tumors often display a complex spectrum of epithelial, hybrid, and mesenchymal cell states, with the mesenchymal marker vimentin playing a crucial role in invasion and metastatic outgrowth Grasset2022Ahmadi-Hadad2024Zhang2021+2 MORE. Long non-coding RNAs (lncRNAs) and microRNAs, such as the miR-200 family and miR-205, are important regulators of EMT and can influence both metastasis and chemoresistance in TNBC Ahmadi-Hadad2024Zhang2021Chen2025.
Tumor Microenvironment and Endothelial Cells
The tumor microenvironment, including specific subtypes of endothelial cells, also contributes to TNBC metastasis. Certain endothelial cell populations within the tumor can promote metastatic behavior, further supporting the spread of cancer cells to distant organs, including the skin .
Signaling Pathways and Molecular Targets
Multiple signaling pathways are implicated in TNBC metastasis, such as integrin/FAK and EGFR pathways. Proteins like Tinagl1 and TIMP-2 have shown potential in suppressing TNBC progression and metastasis by inhibiting these pathways and disrupting EMT, suggesting possible therapeutic strategies Shen2019Peeney2019.
Treatment Advances and Challenges for Metastatic TNBC
Recent advances in TNBC treatment include the use of poly (ADP-ribose) polymerase (PARP) inhibitors and immunotherapy, particularly for tumors expressing PD-L1. However, metastatic TNBC, including cases with skin involvement, remains difficult to treat due to its molecular complexity and lack of effective targeted therapies. Combination approaches using chemotherapy, immunotherapy, and novel agents targeting EMT and the tumor microenvironment are under investigation to improve outcomes Bergin2019Neophytou2018Al-Mahmood2018+1 MORE.
Conclusion
Triple-negative breast cancer is a highly aggressive subtype with a strong tendency for early and widespread metastasis, including to the skin. The process is driven by complex molecular mechanisms involving EMT, the tumor microenvironment, and multiple signaling pathways. While new therapies are emerging, metastatic TNBC continues to pose significant treatment challenges, highlighting the need for ongoing research into targeted interventions and improved management strategies Bergin2019Neophytou2018Grasset2022+7 MORE.
Sources and full results
Most relevant research papers on this topic